Non—muscle-invasive Bladder Cancer Management During BCG Shortages: NYU Case of the Month, February 2020

od Barlow, LaMont J.
Izdano u Rev Urol (2020)

Identification of gallbladder mucin-bilirubin complex in human cholesterol gallstone matrix. Effects of reducing agents on in vitro dissolution of matrix and intact gallstones.

od Smith, B F, LaMont, J T
Izdano 1985

Saccharomyces boulardii protease inhibits Clostridium difficile toxin A effects in the rat ileum.

od Castagliuolo, I, LaMont, J T, Nikulasson, S T, Pothoulakis, C
Izdano 1996

Cell-surface glycosyltransferases in cultured fibroblasts: increased activity and release during serum stimulation of growth.

od LaMont, J T, Gammon, M T, Isselbacher, K J
Izdano 1977

Clostridium difficile toxin A perturbs cytoskeletal structure and tight junction permeability of cultured human intestinal epithelial monolayers.

od Hecht, G, Pothoulakis, C, LaMont, J T, Madara, J L
Izdano 1988

Clostridium difficile toxin A binds colonocyte Src causing dephosphorylation of focal adhesion kinase and paxillin

od Kim, Ho, Rhee, Sang Hoon, Pothoulakis, Charalabos, LaMont, J. Thomas
Izdano 2009

Saccharomyces boulardii Protease Inhibits the Effects of Clostridium difficile Toxins A and B in Human Colonic Mucosa

od Castagliuolo, Ignazio, Riegler, Martin F., Valenick, Leyla, LaMont, J. Thomas, Pothoulakis, Charalabos
Izdano 1999

gp96 Is a Human Colonocyte Plasma Membrane Binding Protein for Clostridium difficile Toxin A

od Na, Xi, Kim, Ho, Moyer, Mary P., Pothoulakis, Charalabos, LaMont, J. Thomas
Izdano 2008

Selective killing of cancer cells by β-lapachone: Direct checkpoint activation as a strategy against cancer

od Li, Youzhi, Sun, Xiangao, LaMont, J. Thomas, Pardee, Arthur B., Li, Chiang J.
Izdano 2003

Isolation and characterization of cDNA clones encoding pig gastric mucin.

od Turner, B S, Bhaskar, K R, Hadzopoulou-Cladaras, M, Specian, R D, LaMont, J T
Izdano 1995

Intravenous immunoglobulin therapy for severe Clostridium difficile colitis

od Salcedo, J, Keates, S, Pothoulakis, C, Warny, M, Castagliuolo, I, LaMont, J, Kelly, C
Izdano 1997

Clostridium difficile toxin A stimulates intracellular calcium release and chemotactic response in human granulocytes.

od Pothoulakis, C, Sullivan, R, Melnick, D A, Triadafilopoulos, G, Gadenne, A S, Meshulam, T, LaMont, J T
Izdano 1988

Saccharomyces boulardii Stimulates Intestinal Immunoglobulin A Immune Response to Clostridium difficile Toxin A in Mice

od Qamar, Amir, Aboudola, Samer, Warny, Michel, Michetti, Pierre, Pothoulakis, Charalabos, LaMont, J. Thomas, Kelly, Ciarán P.
Izdano 2001

Involvement of Ras-related Rho proteins in the mechanisms of action of Clostridium difficile toxin A and toxin B.

od Dillon, S T, Rubin, E J, Yakubovich, M, Pothoulakis, C, LaMont, J T, Feig, L A, Gilbert, R J
Izdano 1995

Characterization of rabbit ileal receptors for Clostridium difficile toxin A. Evidence for a receptor-coupled G protein.

od Pothoulakis, C, LaMont, J T, Eglow, R, Gao, N, Rubins, J B, Theoharides, T C, Dickey, B F
Izdano 1991

pH-dependent conformational change of gastric mucin leads to sol-gel transition.

od Cao, X, Bansil, R, Bhaskar, K R, Turner, B S, LaMont, J T, Niu, N, Afdhal, N H
Izdano 1999

Bovine immunoglobulin concentrate-Clostridium difficile retains C difficile toxin neutralising activity after passage through the human stomach and small intestine

od Warny, M, Fatimi, A, Bostwick, E, Laine, D, Lebel, F, LaMont, J, Pothoulakis, C, Kelly, C
Izdano 1999

Survival of anti-Clostridium difficile bovine immunoglobulin concentrate in the human gastrointestinal tract.

od Kelly, C P, Chetham, S, Keates, S, Bostwick, E F, Roush, A M, Castagliuolo, I, LaMont, J T, Pothoulakis, C
Izdano 1997

CP-96,345, a substance P antagonist, inhibits rat intestinal responses to Clostridium difficile toxin A but not cholera toxin.

od Pothoulakis, C, Castagliuolo, I, LaMont, J T, Jaffer, A, O'Keane, J C, Snider, R M, Leeman, S E
Izdano 1994

Anti-Clostridium difficile bovine immunoglobulin concentrate inhibits cytotoxicity and enterotoxicity of C. difficile toxins.

od Kelly, C P, Pothoulakis, C, Vavva, F, Castagliuolo, I, Bostwick, E F, O'Keane, J C, Keates, S, LaMont, J T
Izdano 1996